Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 713 of 1,261
  1. US 9238692

    Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  2. US 9238838

    Microrna patterns for the diagnosis, prognosis and treatment of melanoma

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  3. US 9238803

    Modified zinc finger binding proteins

    Sangamo Biosciences, Inc. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  4. US 9238684

    SPANX-B polypeptides and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  5. US 9238676

    Peptide and peptidomimetic inhibitors

    RA PHARMACEUTICALS, INC. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  6. US 9238042

    Antisense modulation of interleukins 17 and 23 signaling

    Sarepta Therapeutics, Inc. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  7. US 9238639

    Aromatic ring compound

    Takeda Pharmaceutical Company Limited · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  8. US 9238799

    Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  9. US 9238625

    Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  10. EP 2964255

    BEHANDLUNG UND VORBEUGUNG VON REMOTER ISCHÄMISCHER REPERFUSION

    CSL BEHRING GMBH [DE] · Granted Jan 13, 2016 · Expires Jan 8, 2036

    granted
  11. US 9233086

    Inhibition of WDR5 interaction with its binding partners

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  12. US 9234179

    Materials and methods for generating pluripotent stem cells

    SHANGHAI UNITED STEM CELL BIOTECHNOLOGY CO., LTD. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  13. US 9234016

    Engineered zinc finger proteins for treating trinucleotide repeat disorders

    Sangamo Biosciences, Inc. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  14. US 9233926

    Compounds for stem cell differentiation

    ChemRegen, Inc. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  15. US 9233108

    Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

    Almirall, S.A. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  16. US 9233068

    Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders

    The Regents of the University of California · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  17. US 9233168

    Oligomer-opioid agonist conjugates

    Nektar Therapeutics · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  18. US 9234187

    Modified zinc finger binding proteins

    Sangamo Biosciences, Inc. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  19. US 9234188

    Modified zinc finger binding proteins

    Sangamo Biosciences, Inc. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  20. US 9234196

    Compositions and methods for inhibiting expression of transthyretin

    Alnylam Pharmaceuticals, Inc. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  21. US 9234198

    Multiple exon skipping compositions for DMD

    Sarepta Therapeutics, Inc. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  22. US 9234078

    Conjugated gold nanoparticles

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  23. US 9234017

    Aquaporin-4 peptide compositions and methods of use thereof

    The Regents of the University of California · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  24. US 9233940

    Cyclic peptidomimetic compounds as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.